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Molecular weights of macrolide antibiotics can be determined from either (M + H)+ or 
(M + Met)+, the latter desorbed from alkali metal salt-saturated matrices. The ion chemistry 
of macrolides, as determined by tandem mass spectrometry (MS/MS), is different for ions 
produced as metallated than those formed as (M + H)+ species. An explanation for these 
differences is the location of the charge. For protonated species, the charge is most likely 
situated on a functional group with high proton affinity, such as the dimethylamino group of 
the ammo sugar. The alkali metal ion, however, is bonded to the highly oxygenated 
aglycone. As a result, the collision-activated dissociation spectra of protonated macrolides are 
simple with readily identifiable fragment ions in both the high and low mass regions but no 
fragments in the middle mass range. In contrast, the cationized species give complex spectra 
with many abundant ions, most of which are located in the high mass range. The comple- 
mentary nature of the fragmentation of these two species recommends the study of both by 
MS/MS when determining the structure or confirming the identity of these biomaterials. CJ 
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macrolides are a class of antibiotics that con- 
sist of 12, 14-, or 16-membered lactone agly- 
cones with one or more pendant sugars, at least 
one of which is usually an amino sugar (structures 1,2, 
3, and 4) [l]. Erythromycin A is probably the most 
welNnown member of this class as it is the drug of 
choice for treatment of upper and lower respiratory 
tract infections and mycoplasma pneumonia [z]. All 
macrolides exhibit strong activity against gram-posi- 
tive bacteria and mycoplasma by inhibiting protein 
synthesis in the target organism [3]. 
Mass spectrometic techniques such as electron ion- 
ization (preceded by sample derivatization) [41, laser 
desorption [5], chemical ionization [6], and fast-atom 
bombardment (FAB) [7] have been used to determine 
macrolide antibiotics. Determination of macrolides by 
FAB is not sensitive because the hydrophilic nature of 
the pendant sugars limits the surface activity of these 
and other glycosidic compounds [8] in polar matrices. 
For carbohydrates in general, addition of a nonpolar 
chain [9] as well as selection of an appropriate matrix 
[ill] can serve to increase the sputtering efficiency. 
Pramanik et al. [II] reported enhanced abundances 
of molecular species by the addition of alkali salts to 
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FAB matrices. Aduru and Chait [ 121 also reported that 
the sodium-cationized species of oligosaccharides and 
glycoconjugates dominate the spectrum generated by 
252 CP f lasma desorption when sodium chloride was 
added to the sample. Spectra obtained without added 
sodium chloride show no molecular ions and are dom- 
inated by fragment ions. The formation of cationized 
permethylated monosaccharides upon FAB [13] was 
also reported. Structural information can be obtained 
by collisional activation of the metallated species of 
disaccharides and oligosaccharides [14,15], permethyl- 
ated oligosaccharides [16], and glycosides [17]. Struc- 
tural studies are also informative for alkali-metal- 
cationized fatty acids [ 181, alkali-metal-cationized pep- 
tides [19] and fatty acid esters 1201, alkaline- 
earth-metal-cationized peptides [21], and triterpenoids 
[22] by using collisional activation. Riillgen et al. [23] 
first observed structurally informative differences be- 
tween the decompositions of the (M + Li)* and (M + 
HI+ species of small alcohols, aldehydes, and ketones, 
and a detailed picture of metal ions in mass spectrom- 
etry can be found in a recent review [24]. 
In this article we explore the effects of different 
matrices on the FAB mass spectrum of eight macrolide 
antibiotics. Several matrices along with their alkali- 
metal-salt-saturated counterparts were used to demon- 
strate a method for verification of the molecular 
weights of the antibiotics. More important, the frag- 
mentations of the cationized species (M + Met)+ 
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(where Met refers to the metal species) were founcl to 
be significantly different from those of (M + HI+. These 
differences motivated an investigation of the opportu- 
nities for determining structure by collisional activa- 
tion of both the (M + HI+, and (M + Met)+ ions. The 
emphasis of this study then is those differences and 
their implications with respect to metal-ion interac- 
tions with large, multifunctional molecules. 
Experimental 
Eight different macrolide antibiotics were studied by 
using FAB and tandem mass spectrometry (MS/MS). 
The eight antibiotics are depicted in structures 1, 2, 3, 
and 4. All the antibiotics were obtained from fermenta- 
tion broths and isolated at Schering-Plough Research. 
The antibiotics, which were used without further 
purification, were dissolved in dimethyl sulfoxide 
(DMSO) to a concentration of approximately 1 mg/mL. 
A small volume of solution, generally about 1-2 pL, 
WJ 
3a Desmycosin 
Rj=Mycaminose 
R2=Mycmse 
3b Tylosin 
Rq = Mycaminosyl-mycarwe 
Rp = Mycinose 
3c 23-0-desmycosinyl tylosin 
Rq = Mycarnin~~yl-mycamse 
R>=H 
was syringed onto a copper or stainless steel probe tip 
coated with approximately 1 PL of matrix. Matrices 
that were found to be most appropriate for desorbing 
protonated species were 3-nitrobenzyl alcohol (3-NBA), 
dithiothreitol/dithioerythreitol (5:l mixture) (DTT/ 
DTE), and thioglycerol. The metal-cationized species 
were generated from matrix solutions saturated with 
Lil, NaCl, and KCl. To slow matrix evaporation and/ or 
degradation during desorption, < 1 PL of glycerol 
was added to the probe tip when either 3-NBA or 
thioglycerol or their salt solutions were used as the 
matrix. All matrix reagent materials were obtained 
from Aldrich Chemical Co. (Milwaukee, WI) and were 
used without further purification. 
One instrument used in this study was the VG 
Analytical (Manchester, England) ZAB-T. A brief de- 
scription of this instrument was published recently 
[25]. The instrument is a prototypal BEBE geometry 
mass spectrometer that comprises a Nier-Johnson re- 
verse-geometry design for MS-I and an unusual re- 
verse-geometry Mattauch-Herzog type spectrometer 
for MS-II. MS-II is equipped with an inhomogeneous 
electrostatic analyzer (ESA) and an array detector. 
0 
0 
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The instrument is equipped with a cesium ion gun 
that was operated at 25 kV to desorb the antibiotics by 
the liquid secondary ion mass spectrometry method. 
Collisional activation experiments were performed 
with an accelerating voltage of 8 kV and with the 
collision cell floated at 4 kV. Helium was used as the 
collision gas and was added to the collision cell at a 
level that suppressed the selected ion beam by approx- 
imately 80%. This suppression level yields optimal 
structural information while maintaining the necessary 
sensitivity. The ion of interest was selected at a resolu- 
tion of 1000 (10% valley definition) by MS-I. MS-II was 
operated with object and image slits closed sufficiently 
so that the final slit was fully illuminated, giving a 
slight rounding of the shoulders of the ion signal, to 
maximize ion transmission. The instrument calibration 
in the MS/MS mode identified calibrant peaks to an 
accuracy of f 0.2 u. 
The other instrument was a Kratos MS-50 triple 
analyzer (Kratos Analytical, Manchester, UK), which 
was described previously [26]. Ions were desorbed by 
bombardment with 6-keV argon atoms. The collision- 
activated dissociation (CAD) spectra are nearly identi- 
cal to those taken with the ZAB-T except the resolution 
is poorer and there is some discrimination against low 
mass ions. 
Results and Discussion 
FAB Mass Spectra 
The macrolide antibiotics were desorbed as proto- 
nated, (M + H)+, and cationized, (M + LiY, (M + 
Na)+, (M + K)*, species, and full mass spectra were 
acquired primarily to verify molecular weights. The 
matrix that gives satisfactory abundances of both 
molecular ions and fragments is DTT/DTE or DTT/ 
DTE saturated with the appropriate alkali metal salt. 
Fragment ion abundances are less when 3-NBA or its 
salt solution is used as a matrix, but molecular ion 
abundances are comparable to those observed when 
DTT/ DTE is used. Matrices such as triethanolamine 
(TEA) or hexafluorobutyric acid (HFBA) give poor 
results, and CM + HI+ ions are of low abundance, 
although desorption from alkali metal salt-saturated 
TEA yields adequate quantities of (M + Met)+. Gener- 
ally, the abundance of (M + Met)+ species is some- 
what greater when produced from the alkali-metal- 
cationized antibiotic than that of (M + H)+ ions from 
matrices containing no salt. Similar observations were 
made recently by Aduru and Chait [ 121. 
The results of experiments to determine the analyti- 
cal detection limit of macrolides by using FAB mass 
spectrometry and 3-NBA as a matrix indicate that a 
1-pmol sample is sufficient to give a molecular (M + 
H)+ ion for single ion monitoring. By using a 1-pmol 
sample of erythromycin A, la, a signal-to-noise ratio 
(S/N) of 20 was achieved. Reducing the analyte con- 
centration to 0.1 pmol lowers the S/N to approxi- 
mately 29. Detection limits of l-10 pmol are typical 
for oligosaccharides in polar matrices [27]. Similar re- 
sults were achieved for (M + Met)+ species upon FAB. 
CAD Mass Spectra: Determination of Optimal 
Collisional Activation Conditions 
The CAD spectra of erythromycin A, la, the most 
familiar of the macrolide antibiotics (structure l), yield 
information about the structure of the protonated 
molecule, but high levels (50~80%) of collisional acti- 
vation are required to generate sufficient fragmenta- 
tion for identification purposes (Figure 1). Metastable 
ion decompositions of (erythromycin A + Hl’ gener- 
ate abundant high mass ions that result from elimina- 
tion of water and detachment, accompanied by hydra 
gen transfer, of the nonamino sugar, cladinose, from 
the C-3 position, but fragment ions in the low mass 
range are nearly nonexistent. Low mass ions are ob- 
served, however, as the number of collisions accompa- 
nying activation increases. Most prominent is the amino 
sugar fragment. To obtain the most structurally com- 
plete data, sufficient helium must be added to sup- 
press the [M + HI+ by 50-80%. 
Structure Determinution By Using 
Collisional Activation 
The chemistry observed upon the collisional activation 
of the protonated or metallated forms of 1, 2,3, and 4 
is general even though the aglycone portions of the 
molecules are different. Most of the fragmentation is 
centered at the sugar components of the molecules, 
either as elimination of portions of the sugars or as 
production of fragments for which the charge is 
retained by the sugar. There are, however, distinct 
differences in the fragmentation processes that proto 
nated and metallated antibiotics undergo upon colli- 
- (Clo dinose - H) 
A 
m/z 
Figure 1. Effect of precursor beam suppression on fragmenta- 
tion processes of the (M + H)+ of erythromycin A, la. Spectra 
were acquired with a three sector tandem mass spectrometer. 
Spectra A, B, C, and D were taken after 0%, 20%, 501, and 80% 
precursor beam suppression, respectively. 
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sional activation. We wish to highlight these differ- 
ences. 
The antibiotics studied contain from one to three 
saccharide units, at least one of which is an amino 
sugar. These saccharides are attached to the aglycone 
to give a variety of structure classes of antibiotics: 
containing one saccharide unit, containing two indi- 
vidual sac&ride units individually attached to the 
aglycone ring, containing a disaccharide unit, contain- 
ing three saccharide units individually attached to the 
aglycone, or containing a disaccharide and a monosac- 
charide. To illustrate the chemistry observed upon 
collisional activation, the data are presented for com- 
pounds in increasing order of saccharide complexity. 
The simplest CAD spectrum for this series of com- 
pounds is that of protonated rosaramicin, 2 (see Figure 
2). With only one pendant saccharide entity, rosaram- 
icin does not have many channels for decomposition 
and, thus, primarily gives protonated dehydro des- 
osamine, the amino sugar ion of m/z 158. The ion of 
m/z 174 indicates that glycosidic bond cleavage also 
occurs on the aglycone side of the bond. Elimination of 
the elements of ketene from the ion of m/z 158 gives 
that of m/z 116. No ions of significant abundance are 
observed above m/z 174. The chemistry exhibited by 
the (M + HI+ ion of rosaramicin is consistent with 
protonation of the high proton affinity dimethylamino 
entity of the pendant desosamine. As no fragmenta- 
tions occur from the la&one ring, the proton appears to 
be locked into position on the amino sugar. 
on the sugar side accompanied by hydrogen transfer to 
either the saccharide or the glycosidic oxygen occurs to 
give the ions of m/z 445 and 447, respectively. Similar 
reactions on the aglycone side of the glycosidic bond 
produce the ions of m/z 429 and 431. Fragment ions of 
lower mass result from degradations of the aglycone. 
The ion of m/z 387, as the most abundant fragment, 
likely results from the elimination of ketene from the 
aldehyde side chain of the m/z 429 ion. No assign- 
ment has been made for the ion of m/z 352. A low 
abundance ion of m/z 158 for (dehydro desosamine)+ 
is also observed. The ion of m/z 196 is likely the 
Na-containing analog of the ion of m/z 174 observed 
in the CAD spectrum of the (M + H)+, and the ion of 
m/z 23 is NaC. Losses of small neutrals, such as 
methane, water, ethane, and both dimethyamine and 
methane, occur to give ions of m/z 588, 586,574, and 
543, respectively. 
The collisionally activated fragmentations of the 
metallated species are much more complex. Ions are 
formed by the elimination of the sugar unit, a sugar 
fraction, and the aglycone as seen in the CAD spec- 
trum of (rosaramicin + Na)+ (Figure 2). The ion of 
m/z 475 is formed upon cycloreversion of desosamine 
to eliminate C,H,,NO. Cleavage of the glycosidic bond 
The predominant fragmentations of (M + Na)+ in- 
dicate that the likely location of the sodium ion is on 
the aglycone. Neutral fragments of the saccharide, the 
saccharides themselves, and portions of the macrocycle 
are eliminated, leaving the sodium attached to the 
remaining structure. Only the low abundance ion of 
m/z 196 indicates any sodium ion interaction at the 
saccharide. With the metal ion locked into position on 
the aglycone entity, fragmentations occur remote to the 
charge site [28]. A contrasting observation was made 
for the (M + Na)+ species of steroid glycosides: The 
sodium cation attaches to the aglycone when one sugar 
is present, but on a saccharide when the steroid glyco- 
side has more than one saccharide 1171. 
Antibiotics Containing Two Saccharide Units 
The principal process that occurs upon CA of the 
protonated erythromycin A, la, (Figure 3) involves 
Figure 2. FAR CAD spectra nf (M + 
HI+ (of m/z 582) and (M + Na)+ (of 
m/z 604) ions of rosaramicin, 2. The 
spectra were obtained with a four 
sector tandem mass spectrometer. Ex- 
planations for the location of the prrr 
ton and metal ions are given in the 
text. 
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cleavage at the glycosidic linkage to the nonamino 
sugar to give the Y ion of m/z 576, according to the 
nomenclature suggested by Domon and Costello [29]. 
An ion of m/z 576 is also produced as a result of ion 
source reactions. Its CAD reactions produce the same 
products that are seen in the [M + HI+ spectrum be 
low m/z 576. The ion of m/z 558 may result from 
cleavage of the glycosidic bond on the aglycone side (2 
ion) or from the elimination of water from the ion of 
m/z 576. Two sequential water losses follow. Addi- 
tional fragments are formed via cleavage of either side 
of the glycosidic oxygen of the ammo sugar with 
accompanying hydrogen transfers, generating the B, 
C - 2H, and C ions of m/z 158, 174, and 176, respec- 
tively. According to the proposed nomenclature [29], 
the C ion designation is a shortened version of C + 2H. 
Abiding by the proposed nomenclature, we assign the 
C ion as that of m/z 176 whereas the more abundant 
m/z 174 ion is a C - 2H ion. The C - 2H is more 
abundant than C for amino sugars because the proto 
nation has presumably occurred at the amine and 
cleavage follows as a charge-remote H-transfer from 
the ammo sugar to the departing neutral macrolide. 
The ‘,‘A ion of m/z 116 is formed either in a one-step 
process from (M + H)+ or in a twostep elimination of 
C,H,O from the m/z 158 ion (or C,H,O, from the 
m/z 174 ion). Analogous results were obtained upon 
chemical ionization of other macrolide antibiotics [13]. 
Eliminations of small molecules from the backbone of 
the aglycone ring or from the framework of either 
sugar species do not occur to any measurable extent. 
One of the most significant fragment ions produced 
by decomposition of (erythromycin A + K)+ in the 
source or upon collisional activation is that of m/z 
643, generated via loss of 129 u. Peak-matching experi- 
ments were performed on the source-produced frag- 
ment, at a mass resolution of greater than 30,000, 
Figure 3. FAB CAD spectra of (M + 
H)+ (of m/z 734) and @A + K)+ (of 
m/z 772) ions of erythromycin A, la. 
The spectra were obtained with a four 
sector tandem maaa spectrometer. Ex- 
planations for the location of the pm 
ton and metal ions are given in the 
text. 
Y 4-J 
X 
Scheme I
to establish the exact mass to be 643.3120, which 
fits to within 0.5 ppm the atomic composition of 
C,H,,O,,K’. This ion can be formed upon elimina- 
tion of a C,H,sNO entity via a cycloreversion (‘r5X 
ion) of the amino sugar desosamine. In this way, a 
formyl group remains attached to the glycosidic oxy- 
gen. The ion of m/z 642 is formed in an analogous 
manner by elimination of C,H,,O, from cladinose. 
Other fragment ions produced by collisional activa- 
tion of potassiated-erythromycm A (see Figure 3) re- 
sult from cleavages and rearrangements involving in- 
tact saccharide frameworks. Y ions of m/z 612 and 614 
and of m/z 613 and 615 and Z ions of m/z 596, 598, 
597, and 599 are produced by the elimination of cladi- 
nose and desosamine, respectively. The ion of m/z 511 
likely results from concurrent cycloreversions at both 
sugars. The ion of m/z 439 is produced by two se- 
quential or concurrent cleavages, one of an X and the 
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other a Y cleavage. The ion of nr/z 423 is the potassi- 
ated core a&cone. Decomposition of cationized ery- 
thromycin A also involves elimination of portions of 
the aglycone ring. For example, the ions of m/z 381 
and 353 likely result from the sequential elimination of 
the elements of ketene and water from the m/z 423 
ion. 
The spectra of erythromycin A cationized with other 
alkali metal ions are comparable to that of (M + K) +, 
showing similar ion abundances and suggesting metal- 
independent fragmentation. Riillgen et al. [30] obtained 
analogous results for cationized monosaccharides and 
first suggested that high energy CAD for such species 
is independent of the identity of the metal ion. Others, 
however, report small differences that depend on the 
size of the alkali metal, but the glycosides studied do 
not contain a macrocycle as an aglycone [17, 241. The 
macrocycle may be sufficiently large to coordinate 
strongly K+ as well as Na+ and Li+. 
The fragment ions observed upon collisional activa- 
tion of the (M + HI+ and (M t K)+ ions of four other 
antibiotics, mycinamicin II, 4, desmycosin, 3a, megala- 
losamine, lb, and 23-0-desmycosinyltylosin, 3c, are 
summarized in Tables 1 and 2. The protonated 
macrolides decompose similarly as protonated cry- 
thromycin A and give simple CAD mass spectra; most 
of the fragment ions are of low mass and characteristic 
of the amino sugar. The data support tight location of 
the charge on an amino sugar. The (M + Met)+ species 
of the macrolides fragment in a similar manner as that 
of cationized erythromycin A; that is, many abundant 
fragments are clustered in the high mass region of 
their CAD spectra. These arise from cleavages around 
the glycosidic bonds to eliminate the saccharides; the 
metallated aglycone ring remains intact. Often, the 
only low mass ion is the alkali metal itself. 
Antibiotics Containing Three Sac&wide Units 
Two of the macrolide antibiotics studied here contain 
three saccharide units. Megalomicin A has the same 
structure as megalalosamine but with an additional 
neutral sugar, mycarose, at C-3 of the aglycone ring 
(see structure lc). The two amino sugars do not cause 
significant changes in the fragmentations, which are 
similar to those of erythromycin A. Decomposition of 
protonated megalomicin A occurs principally via the 
two established routes: elimination of the mycarose (to 
give the m/z 733 ion) and formation of a B-ion of m/z 
158 from either desosamine or megosamine. In addi- 
tion, either of the amino sugars can be protonated, 
making elimination of the other amino sugars a facile 
process to produce the ion of m/z 720. Elimination of 
both mycarose and one of the amino sugars results in 
the ion of m/z 576; this is the same species observed 
in the CAD spectrum of fragments from protonated 
erythromycin A, 
The metallated megalomicin A also fragments as 
expected. Elimination of either mycarose or one of the 
amino sugars results in two sets of X-, Y-, and Z-ions. 
In addition, two saccharides are eliminated via ‘j5X 
cleavages, and the final product is abundant. The loss 
of all three saccharides also occurs to produce a potas- 
siated aglycvne of m/z 407. 
Tylosin has a 16-membered aglycone ring with a 
disaccharide unit of mycaminose and mycarose at C-5 
and the monosaccharide mycinose attached at C-14 
(see structure 3b). Consistent with the other macrolide 
antibiotics, (tylosin + H)+ principally decomposes by 
cleavage of the mycaminose glycosidic bond on the 
amino sugar side to form the ion of m/z 174 (Figure 
4). A second decomposition process occurs via hydro- 
gen transfer and cleavage of the mycaminose-mycarose 
Table 1. Fragment ions observed in the CAD spectra of protonated macrolidc antibiotics 
containing two sugars* 
Amino sugar 
Antibiotic Sugar ‘,*A B C-2H 
Mycinamicin II, 4 Desosamine 116 158 174 
(12) (100) (7) 
Desmycosin, 3a Mycaminose 132 174 190 
(15) (100) (5) 
Megalalosamine. 1 b Desosamine 116 158 174 
(4) (loo)** (4P* 
Megosamine 132 
(14) 
Sugar Y +.5x 
Mycinose 552 /554 582 
(2) (3) 
Mycinose 596 /598 626 
(2) (2) 
574 /576+ 604’ 
15) 11) 
23.O-desmycosinyl Mycaminose 132 174 190 Mycarose 598 
tylosin, 3c (19) (100) (5) (22) 
*Mass-to-charge ratio values, relative abundance in percent in parentheses. 
**Cannot dlstmguish between the two amino sugars. 
‘Protonation occurs at one amino sugar; the other amino sugar is eliminated 
Fragmentation nomenclature used is that proposed I” ref. 29. 
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Table 2. Fragment ions observed in the CAD spectra of potassiated macrolide antibiotics containim two sugars* 
Amino sugar Nonamino sugar Other 
Antibiotic Sugar X Y Z Sugar X Y Z fragments Comments 
Mycinamicin II, 4 Desosamine 637 607 591 Mycinose 620 590 574 476,490 Elimination of both sugars 
(13) (61 (8) (19) (7) (< 1) (7).(6) 
314 
(7) 
Desmycosin, 3a Mycaminose 665 635 619 Mycinose 664 634 618 577(m/z 619-42) 
185) (58) (38) (60) (13) 125) (40) 
805 
(42) 
Megalalosamine, lb Desosamine 642 612’ 598 455,423 
Megosamine (26) (7) (3) - (9). (23) 
(isomeric) 582 
(3) 
23-0-desmycosinyl Mycaminose Z, Y, X, Mycarose Z, Y, X, 403 (m/z 445-42) 
tylosin, 3c (15) 
445 463 491 618 636 664 575,521 
(9) (29) 125) (14) (6) (8) (29). 119) 
Aldehyde at C-6 position 
Cleavage on aglycone aide of 
intervening methylene group 
on mycinose I 
Elimination of both sugars 
Aldehyde at C-6 position 
*Mass-to-charge ratio values. relative abundance in percent in parentheses. In all of the CAD spectra, K ’ of m/z 39 is the most 
abundant ion. 
‘An ion of m/r 614 (8%) is also observed and results from hydrogen transfer to the aglycone rather than to the sugar. 
Fragmentation nomenclature used 1s that proposed in ref. 29. 
glycosidic bond to eliminate a mycarose entity and 
form the ion of m/z 772. 
Upon collisional activation of (tylosin + IQ+ (see 
Figure 4), abundant ions are formed by losses of small 
neutrals, such as methanol to give the ion of m/z 922. 
More important, the structurally significant X-, Y-, and 
Z-ions are all formed in large abundance. The frag- 
mentations can be divided into three classes: elimina- 
tion of one saccharide (products from m/z 700 to 850), 
elimination of two saccharides (products from m/z 
550 to 700), and elimination of all the saccharide units 
(products below m/z 450). In addition to the ions 
identified in the fragmentation scheme, those of m/z 
577 and 372 are also structurally important. They iden- 
tify the presence of the aldehyde side chain at C-6 and 
result from the elimination of the elements of ketene 
Figure 4. FAB CAD spectra of CM + 
H)+ (of m/z 916) and (M + K)+ (of 
m/z 954) of tylosin, 3b. The spectra 
were obtained with a four sector tan- 
dem mass spectrometer. Explankiom 
for the location of the proton and 
metal ions are given in the text. 
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from the ion of m/z 619 and from the potassiated bare 
aglycone ring of m/z 414, as was seen for other antibi- 
otics. 
Conclusions 
In summary, the results obtained here point to general- 
ities about the ion chemistry of macrolide antibiotics. 
Metallated species fragment in a way that is consis- 
tent with an alkali-metal interaction at the aglycone, 
whereas the protonated species undergo fragmenta- 
tions remote from the protonated site on an amino 
sugar. The results establish the advantages of obtain- 
ing CAD spectra of both species when the goal is 
determining the structure or identifying these types of 
biomaterials. 
The macrolide antibiotics also illustrate the need 
for unit resolution and correct mass assignments in 
MS/MS. In the case of erythromycin A, for example, 
the saccharides cladinose and desosamine differ in 
mass by only 1 u. In addition, cleavages at the glyco- 
sidic bond occur with hydrogen transfer to either the 
sugar or the aglycone, resulting in two ions of 2-u 
difference. These two factors result in clusters of four 
ions differing by 1 u in the CAD spectra of the metal- 
lated species of erythromycin A. Determination of 
fragmentation mechanisms clearly requires unit mass 
resolving power. 
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